Nuvation Bio Amends Trial Protocols to Speed Progress for New Brain Cancer Treatments
Nuvation Bio has announced a significant shift in its clinical strategy by amending the protocol for its ongoing global Phase 2 study
by 
Josh Weiner
Josh WeinerSponsored Content
